Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuya Inagaki

Showing results (1-10 of 497) with videos related to

Pageof 50
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 3. Pathogenesis and Development of the Disease; 2) Diabetes mellitus characterized by impaired insulin secretion in Japanese]Nobuya Inagaki
Seikagaku. the Journal of Japanese Biochemical Society|August 4, 2004
[Tissue-specific expression of ABC transporters involved in lipid transport]Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 9. Incretin-based therapy for type 2 diabetes mellitus]Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 31, 2011
[Current status and future prospects of diabetes therapy]Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Drug Therapy of Diabetes Mellitus to Prevent Complications]Nobuya Inagaki
Diabetology International|January 4, 2019
Role of GIP receptor signaling in β-cell survivalNorio Harada, Nobuya Inagaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Incretin and incretin-based therapies]Norio Harada, Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 29, 2009
[Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents]Kazuaki Nagashima, Nobuya Inagaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Clinical biomarkers for diabetes mellitus]Shunsuke Yamane, Nobuya Inagaki
Journal of Molecular and Cellular Cardiology|May 25, 2005
Neuroprotection by KATP channelsKatsuya Yamada, Nobuya Inagaki
Pageof 50

Showing results (1-10 of 497) with videos related to

Sort By:
Pageof 50
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 3. Pathogenesis and Development of the Disease; 2) Diabetes mellitus characterized by impaired insulin secretion in Japanese]Nobuya Inagaki
Seikagaku. the Journal of Japanese Biochemical Society|August 4, 2004
[Tissue-specific expression of ABC transporters involved in lipid transport]Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: educational lecture: 9. Incretin-based therapy for type 2 diabetes mellitus]Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 31, 2011
[Current status and future prospects of diabetes therapy]Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Drug Therapy of Diabetes Mellitus to Prevent Complications]Nobuya Inagaki
Diabetology International|January 4, 2019
Role of GIP receptor signaling in β-cell survivalNorio Harada, Nobuya Inagaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Incretin and incretin-based therapies]Norio Harada, Nobuya Inagaki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 29, 2009
[Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents]Kazuaki Nagashima, Nobuya Inagaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Clinical biomarkers for diabetes mellitus]Shunsuke Yamane, Nobuya Inagaki
Journal of Molecular and Cellular Cardiology|May 25, 2005
Neuroprotection by KATP channelsKatsuya Yamada, Nobuya Inagaki
Pageof 50